Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 10, pp. e1009037-e1009037
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 335
Carbon nanotube field-effect transistor (CNT-FET)-based biosensor for rapid detection of SARS-CoV-2 (COVID-19) surface spike protein S1
Mazin A. Zamzami, G. Rabbani, Abrar Ahmad, et al.
Bioelectrochemistry (2021) Vol. 143, pp. 107982-107982
Open Access | Times Cited: 168
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Michelle A. Erickson, Elizabeth M. Rhea, Rachel C. Knopp, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2681-2681
Open Access | Times Cited: 129
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
Koen Vandyck, Jérôme Deval
Current Opinion in Virology (2021) Vol. 49, pp. 36-40
Open Access | Times Cited: 129
A cohort autopsy study defines COVID-19 systemic pathogenesis
Xiao-Hong Yao, Tao Luo, Yu Shi, et al.
Cell Research (2021) Vol. 31, Iss. 8, pp. 836-846
Open Access | Times Cited: 128
Mutation Rates, Mutation Frequencies, and Proofreading-Repair Activities in RNA Virus Genetics
Esteban Domingo, Carlos García‐Crespo, Rebeca Lobo-Vega, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1882-1882
Open Access | Times Cited: 103
Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons
Weili Kong, Mauricio Montaño, Michael J. Corley, et al.
mBio (2022) Vol. 13, Iss. 6
Open Access | Times Cited: 74
The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness
Kyumin Kim, Peter Calabrese, Shanshan Wang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 72
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection
Linda N. Geng, Hector Bonilla, Haley Hedlin, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1024-1024
Open Access | Times Cited: 27
Mutational signature dynamics indicate SARS-CoV-2’s evolutionary capacity is driven by host antiviral molecules
Kieran D. Lamb, Martha M. Luka, Megan Saathoff, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011795-e1011795
Open Access | Times Cited: 16
The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins
Kristina V. Tugaeva, Dorothy E. D. P. Hawkins, Jake L. R. Smith, et al.
Journal of Molecular Biology (2021) Vol. 433, Iss. 8, pp. 166875-166875
Open Access | Times Cited: 84
Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2
Elisa Saccon, Xi Chen, Flora Mikaeloff, et al.
iScience (2021) Vol. 24, Iss. 5, pp. 102420-102420
Open Access | Times Cited: 64
Organ-specific genome diversity of replication-competent SARS-CoV-2
Jolien Van Cleemput, Willem van Snippenberg, Laurens Lambrechts, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Pathophysiology of infection with SARS‐CoV‐2—What is known and what remains a mystery
Siddharth Sridhar, John Nicholls
Respirology (2021) Vol. 26, Iss. 7, pp. 652-665
Open Access | Times Cited: 58
The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection
Mathias Martins, Gabriela Mansano do Nascimento, Mohammed Nooruzzaman, et al.
Journal of Virology (2022) Vol. 96, Iss. 17
Open Access | Times Cited: 57
Historical Perspective on the Discovery of the Quasispecies Concept
Esteban Domingo, Carlos García‐Crespo, Celia Perales
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 51-72
Open Access | Times Cited: 55
Extracellular Vimentin as a Target Against SARS‐CoV‐2 Host Cell Invasion
Łukasz Suprewicz, Maxx Swoger, Sarthak Gupta, et al.
Small (2021) Vol. 18, Iss. 6
Open Access | Times Cited: 55
Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID
Denise Goh, Jeffrey Chun Tatt Lim, Sonia Bilbao Fernaíndez, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
The SARS-CoV2 envelope differs from host cells, exposes procoagulant lipids, and is disrupted in vivo by oral rinses
Zack Saud, Victoria J. Tyrrell, Ανδρέας Ζαραγκούλιας, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 6, pp. 100208-100208
Open Access | Times Cited: 41
Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19
Aiwei Zhu, Fernando Real, Claude Capron, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 7
Open Access | Times Cited: 40
Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-19
Carlla Assis Araújo-Silva, Alléxya A. A. Marcos, Paula M. Marinho, et al.
JAMA Ophthalmology (2021) Vol. 139, Iss. 9, pp. 1015-1015
Open Access | Times Cited: 45
New Insights into the Role of the Complement System in Human Viral Diseases
Ewa Ostrycharz, Beata Hukowska-Szematowicz
Biomolecules (2022) Vol. 12, Iss. 2, pp. 226-226
Open Access | Times Cited: 31
A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2
Liangqin Tong, Xiaoping Xiao, Min Li, et al.
Nature Metabolism (2022) Vol. 4, Iss. 5, pp. 547-558
Open Access | Times Cited: 31
SARS‐CoV‐2 infection and lytic reactivation of herpesviruses: A potential threat in the postpandemic era?
Jungang Chen, Jiao Song, Lu Dai, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5103-5111
Open Access | Times Cited: 28
Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
J. Pedro Teixeira, Sharon Barone, Kamyar Zahedi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2242-2242
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top